PGEN Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: April 02, 2026
Report Source: 2025 Annual Report
Precigen Inc. Stock Analysis PGEN
Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. The company is headquartered in Germantown, Maryland and currently employs 160 full-time employees. The company went IPO on 2013-08-08. The Company’s proprietary technology platforms develop product candidates designed to target urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. The company has developed a pipeline of therapies across multiple indications. The Company’s segments include Biopharmaceuticals and Exemplar. The Biopharmaceuticals segment is primarily comprised of the Company's legal entities as well as royalty interests in therapeutics and therapeutic platforms from companies not controlled by the Company. The Exemplar is composed of Exemplar Genetics LLC, doing business as Precigen Exemplar, its wholly owned subsidiary focused on developing research models and services for healthcare research applications.
Read More Precigen Inc (PGEN) Chart
Key Statistics of Precigen Inc (PGEN)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$4.54Volume
3.62MP/E Ratio (TTM)
-52 Week Range
Market Cap
1.53BAvg. Volume
3.21MDividend Yield
-Financial Metrics & Statements of Precigen Inc (PGEN)
FAQ's for Precigen Inc (PGEN)
- According to Musaffa’s Shariah screening methodology, Precigen Inc (PGEN) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.